Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Rejuvalyte Oy
OY
Active
Y-tunnus 2802655-2
C/O Ann Plough Keinutie 11O-1180, 00940
Helsinki
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2016 · 9 years old
— employees
Share
Finland
/
Companies
/
Manufacture of pharmaceutical preparations
/
Rejuvalyte Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
0M
-1M
-1M
2018: 0M
0M
2018
2019: 0M
0M
2019
2020: 0M
0M
2020
2021: 0M
0M
2021
EBITDA
EUR millions
0M
0M
0M
-1M
-1M
2018: 0M
0M
2018
2019: 0M
0M
2019
2020: 0M
0M
2020
2021: 0M
0M
2021
Income statement
EUR thousands
Item
2021
2020
2019
2018
Revenue
0
0
0
0
Staff expenses
—
—
1
−25
EBITDA
87
−3
1
−28
Depreciation & amort.
—
—
—
—
EBIT
87
−3
1
−28
Net financials
0
0
−0
−0
Profit before tax
87
−3
1
−28
Tax
−0
−1
1
−0
Net profit
87
−2
−0
−28
Balance sheet
EUR thousands
Item
2021
2020
2019
2018
Total assets
0
1
1
2
Equity
0
−87
−85
−84
Long-term debt
—
85
85
85
Short-term debt
0
3
0
1
Total debt
0
88
86
86
Financial ratios
5-year trend
EBITDA margin
>999 %
This company
15,8 %
Market median
This company
Market median
>999% above market
2018
2021
Equity ratio
0,0 %
This company
38,2 %
Market median
This company
Market median
100% below market
2018
2021
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2018
2021
Net profit margin
>999 %
This company
8,1 %
Market median
This company
Market median
>999% above market
2018
2021
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2018
2021
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2018
2021
Annual reports & filings
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
View
PDF
More on Rejuvalyte Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
